Submit your innovations to have your projects reviewed by R&D decision-makers in companies across our global industry network working on improving human health by harnessing the microbiome. Through our latest campaign, we’re looking to initiate meaningful connections that lead to the commercialisation and deployment of new solutions targetting the microbiome to improve health. 

Through this campaign, we are inviting academic researchers and technology transfer offices to share with us non-confidential details of research and expertise that will address non-communicable, infectious, inflammatory, or metabolic diseases such as diabetes and cancer by leveraging the microbiome. We are also looking to uncover technologies that will lead to the development of new microbiome therapeutics and treatments to improve gut health and oral health.

For this campaign, we are working with industry partners who are committed to creating patient-driven solutions that leverage the microbiome to improve human health – Caelus Health, VIC Technology Venture Development, and Colgate-Palmolive. 

These companies have shared their R&D priorities and academic partnering requirements through one-page interest documents (links below) and will be presenting them in more detail through a series of online ‘industry partnering opportunity’ webinars (register for these here).

 Through this campaign, we aim to start meaningful conversations that support the development and deployment of technologies that ensure healthy lives for all and promote well-being at all ages.

For more information on our Global Challenges campaigns visit our FAQs page.

If you have questions or want to know more about this campaign, please share your queries to and a member of our team will get back to you promptly.


How does the campaign work?

Submitting research or technologies to the campaign and having them disseminated to industry is free for all TTOs and academics and doesn’t require a subscription to IN-PART.

Our role in the academia-industry ecosystem is to simplify the initial connection between academia and industry. We start the conversations, leave the experts to explore and establish collaborations, and don’t take success feeds from successful partnerships. 

Submissions to the campaign will be disseminated to industry teams with aligned interests through the fourth quarter of 2022, and will feature in our post-campaign content and white paper profiling R&D trends in this space.

We launched this Global Challenges campaign on Monday 26th September, and the deadline for submissions is Monday 7th November.


Who should respond to the campaign?

We want to hear from any researchers who are working on innovations that leverage the microbiome to prevent disease and improve human health. We also want to hear from university technology transfer and research commercialisation professionals that can provide non-confidential details of their work or projects at their institute.

This is not limited to universities that have a subscription to IN-PART; we encourage everyone in academia who is working on microbiome projects to submit their work, with no need to set up a subscription.


What research should you submit?

This campaign has been informed by leading companies and stakeholders who are working on the relationship between the microbiome, health and disease, including Caelus Health, VIC Technology Venture Development, and Colgate-Palmolive. Their specific R&D and external innovation priorities for academic collaborations can be found through the following links:

A full breakdown of the most pressing research topics we’ve identified to be of greatest importance can be found in the submission form.

In addition to our main campaign partners, we also have an extended network of companies working in the microbiome space. We will be disseminating the directory of campaign submissions amongst this network whose interests cover every angle of microbiome-related R&D including gut health, IBD, cancer, AI and metabolomics. Some of these companies have also shared their specific research priorities:

How to submit your research, expertise or technologies:

If you are an academic researcher, or you work in a technology transfer office that isn’t subscribed to IN-PART’s matchmaking platform, Connect: 

Outline non-confidential details of your project, research, or technology in the submission form below and submit it by email to (there will be no costs from IN-PART to engage with this campaign at any stage).

If your technology transfer office is subscribed to IN-PART:

  1. Submit new technologies and opportunities directly through your institute’s dashboard:
  2. If your technology transfer office is subscribed to IN-PART and you have opportunities listed on the platform that fit the criteria of this campaign:

Contact your institute’s account manager at IN-PART to highlight these for inclusion in our industry dissemination programme, open research directory, white paper, and associated communications around the campaign.

Updates to existing technologies will also be distributed to companies with aligned interests.

For more information on our Global Challenges campaigns visit our FAQs page. 

If you have questions or want to know more about this campaign, please share your queries to and a member of our team will get back to you promptly.


Further details:

  • Information about your project or technology will be distributed to industry R&D teams with aligned research interests through our online matchmaking platform.
  • Submitting your work does not require a subscription to our platform, there will be no costs from IN-PART at any stage.
  • Support from our team of STEM experts will be provided where required to review and quality-control submissions.
  • Any information sent to us should be non-confidential.
  • If you are aware of academics, research or technology transfer taking place to prevent disease using the microbiome, please share this document with them.
  • A maximum of 6  submissions can be made per person and we reserve the right to only accept research that is aligned with the aims and themes outlined in the call. 
  • For subscribed universities with a submission limit for IN-PART, any new technologies that are submitted to the global challenge will not count towards your submission total. Eight weeks after the call closes, this exemption will no longer apply and you may be asked to unlist technologies and/or upgrade your submission limit if your current limit is exceeded.
  • Universities with relevant technologies already on IN-PART can email their University Liaison Officer to request their inclusion in our open research directory, white paper, and associated communications around the campaign.


Campaign partners

This campaign is being run with support from:

ASTP are Europe’s premier association of knowledge transfer professionals whose work aims to improve the quality of impact that public research has on the economy and society. Learn more.

PraxisAuril are a world-leading professional association for knowledge exchange practitioners, whose network includes 5000+ KE professionals. Learn more.


Written by Frances Wilkinson. Edited by Anabel Bennett and Joe Ferner.

Copyrights reserved unless otherwise agreed – IN-PART Publishing Ltd., 2022: ‘Seeking academic research investigating the relationship between the microbiome, health and disease’

About IN-PART:

We believe brilliant connections can solve real-world problems. We match research pioneers from academia with decision-makers in industry sectors striving for a greater positive impact.

Our goal is to enable connections from around the world to match academic research with industry on a level playing field. Through our intelligent, matchmaking platform we showcase leading university innovations and connect academics with an international community of decision-makers in industry, creating meaningful dialogue and partnership.


Connect, a digital partnering platform for university-industry collaboration.

250+ universities and research institutes around the world currently showcase their research and innovation on IN-PART to find new collaboration partners in industry. R&D teams get free access to the platform (create an account here). There are no hidden costs and we don’t claim downstream success fees.


Discover, a bespoke scouting service for open innovation.

Through Discover, corporate R&D teams can leverage our extended academic network, which reaches multiple teams across 2,400+ universities and research institutes worldwide. In response to a specific research requirement or challenge, Discover enables R&D teams to identify new opportunities for commercialisation or to solicit proposals for new research.

Interested in speaking with our Discover team? Request a demo |  TTO or academic? Sign-up for weekly Discover emails.


IN-PART Blog Global Challenge- microbiome - inline image

Image credit:  CDC / Unsplash

WHITE PAPER OUT NOWMicrobiome research trends:

Leveraging the microbiome to prevent disease and improve health